Cas No.: | 697235-38-4 |
Chemical Name: | 1H-Cyclopenta[b]benzofuran-2-carboxylic acid, 6-[[(2S,3R,6R)-6-[(1R)-1,2-dihydroxyethyl]-3-methoxy-1,4-dioxan-2-yl]oxy]-2,3,3a,8b-tetrahydro-1,8b-dihydroxy-8-methoxy-3a-(4-methoxyphenyl)-3-phenyl-, methyl ester, (1R,2R,3S,3aR,8bS)- |
Synonyms: | (-)-Silvestrol |
SMILES: | COC1=CC=C([C@]23[C@H](C4=CC=CC=C4)[C@@H](C(OC)=O)[C@@H](O)[C@@]2(O)C2C(=CC(O[C@H]4[C@H](OC)OC[C@H]([C@@H](CO)O)O4)=CC=2OC)O3)C=C1 |
Formula: | C34H38O13 |
M.Wt: | 654.657731533051 |
Purity: | >98% |
Sotrage: | 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO |
Description: | Silvestrol is a potential anticancer rocaglate derivative from Aglaia foveolata, induces apoptosis in cancer cells through the mitochondrial/apoptosome pathway; effectively targets the cyclin/CDK/Rb pathway, and additionally induces cytotoxicity via intrinsic apoptosis, exhibits low nanomolar potency both in MCL cell lines and primary MCL tumor cells; demonstrates B-cell selective activity in chronic lymphocytic leukemia and acute lymphoblastic leukemia in vitro and in vivo. |